FDA
-
-
-
-
-
-
-
LifeMD offers Ozempic at $499 monthly via Novo Nordisk partnership
-
-
-
-
-
-
-
LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients
-
-
-
-
-
-
-
These stocks are near-term opportunity to invest in the GLP-1 space
-
-
-
-
-
-
-
LifeMD, Inc. Reports First Quarter 2022 Results
-
-
-
-
-
-
-
Pre-Open Stock Movers 05/14: (BNGO) (PLUG) (FSR) Higher; (CRMD) (PLT) (ABCL) Lower (more...)
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

